Paul Offit博士已辞去林业发展局疫苗委员会主席的职务,加入卫生与公众服务部。 Dr. Paul Offit has resigned as FDA vaccine committee chair to join the Department of Health and Human Services.

林业发展局疫苗及相关生物产品咨询委员会主席Paul Offit博士已下台,在卫生与公众服务部内担任新职务,标志着负责审查疫苗安全和功效的重要联邦咨询机构的领导力发生变化。 Dr. Paul Offit, chairman of the FDA’s Vaccines and Related Biological Products Advisory Committee, has stepped down to take a new role within the Department of Health and Human Services, marking a leadership change in a key federal advisory body responsible for reviewing vaccine safety and efficacy. 这一立即生效的过渡是随着美国继续监测新出现的传染病和疫苗开发情况而开始的。 The transition, effective immediately, comes as the U.S. continues to monitor emerging infectious diseases and vaccine development.